Department of Medical Microbiology, Royal Infirmary of Edinburgh, 51 Little France Crescent, Old Dalkeith Road, Edinburgh EH16 4SA, UK.
J Clin Pathol. 2008 Jul;61(7):841-3. doi: 10.1136/jcp.2008.055376. Epub 2008 Apr 15.
An evaluation of Chromogenic MRSA medium (CMRSA), MRSASelect (MRSAS) and Oxacillin Resistance Screening Agar (ORSA) was performed to determine the optimum medium providing a rapid and sensitive method for methicillin-resistant Staphylococcus aureus (MRSA) detection.
A total of 632 clinical specimens were cultured on the three media in first phase of the study, while 720 clinical specimens were cultured on CMRSA and ORSA in the second phase.
The sensitivity and specificity, respectively, of the media in the first phase were: CMRSA 88.9% and 98.45%; MRSAS 92.1% and 99.1%; ORSA (24 h incubation) 68.3% and 98.8%; and ORSA (48 h incubation) 85.7% and 96.3%. In the second phase the sensitivity and specificity, respectively, were CMRSA 91.2% and 98.6%; ORSA (24 h incubation) 58.9% and 98.2%; and ORSA (48 h incubation) 85.6% and 95.6%. The positive predictive values of the two chromogenic media were higher than that for ORSA. There were fewer false-positive results with the chromogenic media (1.4% for CMRSA and 0.8% for MRSAS) compared with ORSA (3.3%).
Performing latex agglutination tests on growth from chromogenic media provides results for 93.8% of MRSA isolates within 24 h. There is a small increase in cost of chromogenic media compared with ORSA ( pound28 for MRSAS, and pound36 for CMRSA, per 1000 specimens) and direct agglutination tests ( pound80 per 1000 specimens). However early availability of MRSA screening results can reduce the burden of MRSA in hospitals because of early implementation of infection control measures.
评估显色性耐甲氧西林金黄色葡萄球菌培养基(CMRSA)、MRSASelect(MRSAS)和苯唑西林耐药筛选琼脂(ORSA),以确定一种快速、灵敏的耐甲氧西林金黄色葡萄球菌(MRSA)检测方法。
在第一阶段的研究中,将 632 份临床标本分别接种于三种培养基上进行培养,在第二阶段的研究中,将 720 份临床标本分别接种于 CMRSA 和 ORSA 培养基上进行培养。
第一阶段三种培养基的灵敏度和特异性分别为:CMRSA 为 88.9%和 98.45%;MRSAS 为 92.1%和 99.1%;ORSA(24 小时孵育)为 68.3%和 98.8%;ORSA(48 小时孵育)为 85.7%和 96.3%。在第二阶段,CMRSA 的灵敏度和特异性分别为 91.2%和 98.6%;ORSA(24 小时孵育)为 58.9%和 98.2%;ORSA(48 小时孵育)为 85.6%和 95.6%。两种显色培养基的阳性预测值均高于 ORSA。与 ORSA(3.3%)相比,显色培养基的假阳性结果更少(CMRSA 为 1.4%,MRSAS 为 0.8%)。
对显色培养基上生长的细菌进行乳胶凝集试验,可在 24 小时内得到 93.8%的 MRSA 分离株的结果。与 ORSA(每 1000 份标本 MRSAS 为 28 英镑,CMRSA 为 36 英镑)和直接凝集试验(每 1000 份标本 80 英镑)相比,显色培养基的成本略有增加。然而,早期获得 MRSA 筛查结果可以减少医院中 MRSA 的负担,因为可以早期实施感染控制措施。